Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Vance-Bryan

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Pharmacotherapy|March 1, 1995
Prolonged neuromuscular blockade in two critically ill patients treated with atracuriumL L Hoey, S M Joslin, A Nahum, et al.
Journal of Clinical Pharmacology|October 1, 1993
Comparison of vancomycin pharmacokinetics in hospitalized elderly and young patients using a Bayesian forecasterD R Guay, K Vance-Bryan, S Gilliland, et al.
Pharmacotherapy|May 1, 1996
Resistance to nondepolarizing neuromuscular blocking agentsS J Tschida, K J Graupe, L L Hoey, et al.
Journal of Clinical Pharmacology|December 1, 1992
Pharmacotherapy and pharmacodynamics in the management of bacterial infectionJ C Rotschafer, R A Zabinski, K J Walker, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1992
Investigation of the early killing of Staphylococcus aureus by daptomycin by using an in vitro pharmacodynamic modelK Vance-Bryan, T A Larson, J C Rotschafer, et al.
The Annals of Pharmacotherapy|July 1, 1993
Response to pancuronium after loss of atracurium-induced neuromuscular blockadeK J Kelly, D M Clarens, P R Kohls, et al.
Therapeutic Drug Monitoring|February 1, 1994
Bayesian forecasting of serum vancomycin concentrations with non-steady-state sampling strategiesK A Rodvold, J C Rotschafer, S S Gilliland, et al.
The Journal of Burn Care & Rehabilitation|March 1, 1997
Wide variation in single, daily-dose aminoglycoside pharmacokinetics in patients with burn injuriesL L Hoey, S J Tschida, J C Rotschafer, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1990
Assessment of effects of protein binding on daptomycin and vancomycin killing of Staphylococcus aureus by using an in vitro pharmacodynamic modelM W Garrison, K Vance-Bryan, T A Larson, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1993
Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting techniqueK Vance-Bryan, D R Guay, S S Gilliland, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Pharmacotherapy|March 1, 1995
Prolonged neuromuscular blockade in two critically ill patients treated with atracuriumL L Hoey, S M Joslin, A Nahum, et al.
Journal of Clinical Pharmacology|October 1, 1993
Comparison of vancomycin pharmacokinetics in hospitalized elderly and young patients using a Bayesian forecasterD R Guay, K Vance-Bryan, S Gilliland, et al.
Pharmacotherapy|May 1, 1996
Resistance to nondepolarizing neuromuscular blocking agentsS J Tschida, K J Graupe, L L Hoey, et al.
Journal of Clinical Pharmacology|December 1, 1992
Pharmacotherapy and pharmacodynamics in the management of bacterial infectionJ C Rotschafer, R A Zabinski, K J Walker, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1992
Investigation of the early killing of Staphylococcus aureus by daptomycin by using an in vitro pharmacodynamic modelK Vance-Bryan, T A Larson, J C Rotschafer, et al.
The Annals of Pharmacotherapy|July 1, 1993
Response to pancuronium after loss of atracurium-induced neuromuscular blockadeK J Kelly, D M Clarens, P R Kohls, et al.
Therapeutic Drug Monitoring|February 1, 1994
Bayesian forecasting of serum vancomycin concentrations with non-steady-state sampling strategiesK A Rodvold, J C Rotschafer, S S Gilliland, et al.
The Journal of Burn Care & Rehabilitation|March 1, 1997
Wide variation in single, daily-dose aminoglycoside pharmacokinetics in patients with burn injuriesL L Hoey, S J Tschida, J C Rotschafer, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1990
Assessment of effects of protein binding on daptomycin and vancomycin killing of Staphylococcus aureus by using an in vitro pharmacodynamic modelM W Garrison, K Vance-Bryan, T A Larson, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1993
Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting techniqueK Vance-Bryan, D R Guay, S S Gilliland, et al.
Pageof 3